Jeffrey Harbold Jr, DO | |
1720 S Beckham Ave Ste 102, Tyler, TX 75701-4437 | |
(903) 618-2125 | |
Not Available |
Full Name | Jeffrey Harbold Jr |
---|---|
Gender | Male |
Speciality | Dermatology |
Experience | 9 Years |
Location | 1720 S Beckham Ave Ste 102, Tyler, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700260197 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | R2868 (Texas) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oliver Street 5.01(a) Inc | 0042464125 | 141 |
News Archive
Pregnant patients in Colorado may be told about parenting and adoption, but not abortion. This is according to a new study led by Kate Coleman-Minahan of the University of Colorado College of Nursing published in the Journal of Midwifery and Women's Health.
Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").
Roche Holdings, Inc. (the "Offeror") announced today the final results of its previously announced tender offer (the "Offer") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2.2 billion (the "Maximum Tender Amount") the 5.25% Senior Notes due 2035 issued by the Offeror's subsidiary Genentech, Inc.
QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.
› Verified 1 days ago
Entity Name | Oasis Dermatology Group, Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619099124 PECOS PAC ID: 5890703508 Enrollment ID: O20060322000300 |
News Archive
Pregnant patients in Colorado may be told about parenting and adoption, but not abortion. This is according to a new study led by Kate Coleman-Minahan of the University of Colorado College of Nursing published in the Journal of Midwifery and Women's Health.
Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").
Roche Holdings, Inc. (the "Offeror") announced today the final results of its previously announced tender offer (the "Offer") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2.2 billion (the "Maximum Tender Amount") the 5.25% Senior Notes due 2035 issued by the Offeror's subsidiary Genentech, Inc.
QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.
› Verified 1 days ago
Entity Name | Oliver Street 5.01(a) Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457695413 PECOS PAC ID: 0042464125 Enrollment ID: O20130128000189 |
News Archive
Pregnant patients in Colorado may be told about parenting and adoption, but not abortion. This is according to a new study led by Kate Coleman-Minahan of the University of Colorado College of Nursing published in the Journal of Midwifery and Women's Health.
Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").
Roche Holdings, Inc. (the "Offeror") announced today the final results of its previously announced tender offer (the "Offer") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2.2 billion (the "Maximum Tender Amount") the 5.25% Senior Notes due 2035 issued by the Offeror's subsidiary Genentech, Inc.
QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey Harbold Jr, DO 5310 Harvest Hill Rd Ste 290, Dallas, TX 75230-5826 Ph: (214) 420-0650 | Jeffrey Harbold Jr, DO 1720 S Beckham Ave Ste 102, Tyler, TX 75701-4437 Ph: (903) 618-2125 |
News Archive
Pregnant patients in Colorado may be told about parenting and adoption, but not abortion. This is according to a new study led by Kate Coleman-Minahan of the University of Colorado College of Nursing published in the Journal of Midwifery and Women's Health.
Aptilon Corporation ("Aptilon" or the "Corporation") (TSX-V: APZ), a leading provider of physician access through its innovative alternative sales and marketing channel, today announced that it has acquired from Direct Medical Data, LLC ("DMD"), of Illinois, and BLM Incorporated ("BLM"), of Illinois, substantially all DMD and BLM assets related to their healthcare marketing services (the "Purchased Assets").
Roche Holdings, Inc. (the "Offeror") announced today the final results of its previously announced tender offer (the "Offer") to purchase for cash for a combined aggregate purchase price (exclusive of accrued and unpaid interest) of up to $2.2 billion (the "Maximum Tender Amount") the 5.25% Senior Notes due 2035 issued by the Offeror's subsidiary Genentech, Inc.
QRxPharma announced today initiation of the Company's first Phase 1 trial to evaluate the pharmacokinetic (PK) profiles of experimental controlled-release (CR) morphine and oxycodone formulations that will be incorporated into MoxDuo®CR. MoxDuo®CR contains a fixed 3:2 morphine:oxycodone combination and is intended to be dosed twice daily in patients experiencing chronic pain, an approximately US$7 billion dollar market worldwide.
› Verified 1 days ago
Shanna Burris Meads, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1367 Dominion Plz, Tyler, TX 75703 Phone: 903-534-6200 | |
Stephen John Beck, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1367 Dominion Plz, Tyler, TX 75703 Phone: 903-534-6200 Fax: 903-939-0755 | |
Bradley Scott Graham, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1367 Dominion Plaza, Tyler, TX 75703 Phone: 903-534-6200 | |
Alma Criseida Berlingeri Ramos, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1367 Dominion Plz, Tyler, TX 75703 Phone: 903-534-6200 Fax: 903-939-0755 | |
Elizabeth Stripling Morris, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1367 Dominion Plaza, Tyler, TX 75703 Phone: 903-534-6200 | |
Lawrence Lazelle Anderson, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1367 Dominion Plaza, Tyler, TX 75703 Phone: 903-534-6200 | |
Thomas Lambert Jr., MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5791 Copeland Rd, Tyler, TX 75703 Phone: 903-509-2020 |